The UK is slowly progressing towards a situation where it may be possible...
- The doctor will see you now: making the whole patient-GP relationship virtual
- Medtronic launches Accurian RF ablation system in US
- FDA clears Alphatec neuromonitoring system for spine surgery
- Biotronik gets US regulatory approval for Orsiro stent
- Abbott and Novo Nordisk to offer integrated solution for diabetes
FDA clears NeuroSigma’s Monarch device to treat ADHD
The US Food and Drug Administration has granted marketing clearance for Monarch, an external trigeminal nerve stimulation system developed by NeuroSigma, to treat attention deficit hyperactivity disorder.
Intact gets FDA approval for Tack Endovascular System
Vascular has received approval from the US Food and Drug Administration (FDA) for its tissue tear repair device.
Five ways technology will shape the future of surgery
In the context of the transformative impact technology has had on the 21st century so far, the UK Royal College of Surgeons (RCS) has commissioned a ‘Future of Surgery’ report to look into the effect of technological advances like robot-assisted surgery, genomic testing, 3D bio-printing, AI, and, finally, AR and VR.
Study finds electrostimulation boosts working memory
Researchers at Boston University have discovered that an electrostimulation of the brain (ESB) technique could be used to improve working memory.
The doctor will see you now: making the whole patient-GP relationship virtual
The UK is slowly progressing towards a situation where it may be possible for a patient’s entire relationship with primary healthcare providers, like GPs, to be virtual. From ensuring quick access to patient data, to the patient- doctor consultation and from ordering prescriptions to tracking adherence and feeding back data, a seamless virtual cycle is entirely imaginable– but how will it work in real life?
TherOx’s new heart attack therapy secures FDA approval
TherOx has received premarket approval from the US Food and Drug Administration (FDA) for its SuperSaturated Oxygen (SSO2) therapy to reduce infarct size in heart attack patients.
Avanos Medical to reduce opioid use with pain management pump
Avanos Medical has secured US Food and Drug Administration (FDA) 501(k) clearance for its postoperative pain management device ON-Q Bolus.
AngioDynamics to study NanoKnife in pancreatic cancer
AngioDynamics has received approval from the US Food and Drug Administration (FDA) for an investigational device exemption (IDE) application of its NanoKnife System in the treatment of stage III pancreatic cancer.
Read our magazine
Medical Technology is the essential reading material for decision-makers in the medical device industry, bringing you the latest news and analysis in an exciting, interactive format.
Rolf Rihs has been working at assembly system manufacturer Mikron Automation for nearly 17 years. Over that time, he has…